Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/117498
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Gram-positive and gram-negative antibiotic activity of asymmetric and monomeric robenidine analogues
Author: Russell, C.C.
Stevens, A.
Pi, H.
Khazandi, M.
Ogunniyi, A.
Young, K.A.
Baker, J.R.
McCluskey, S.N.
Page, S.W.
Trott, D.J.
McCluskey, A.
Citation: ChemMedChem, 2018; 13(23):2573-2580
Publisher: Wiley
Issue Date: 2018
ISSN: 1860-7179
1860-7187
Statement of
Responsibility: 
Cecilia C. Russell, Andrew Stevens, Hongfei Pi, Manouchehr Khazandi, Abiodun D. Ogunniyi, Kelly A. Young, Jennifer R. Baker, Siobhann N. McCluskey, Stephen W. Page, Darren J. Trott and Adam McCluskey
Abstract: Desymmetrisation of robenidine 1, N',2-bis((E)-4-chlorobenzylidene)hydrazine-1-carboximidhydrazide, and the introduction of imine alkyl substituents gave good antibiotic activity. Of note was the increased potency of 17 and 20 against VRE with 20 the most active, MIC of 0.5 μg mL-1. Analogues 2, 14, 17, 19 and 20 were equipotent or more potent than the lead 1. Introduction of an indole moiety, 30, resulted in the most MRSA active robenidine analogue, MIC of 1.0 μg mL-1. Imine C=NH isosteres (C=O / C=S) were inactive. Monomeric analogues, 33-35 were 16 - 64 μg mL-1 active against MRSA and VRE. Analogue 36, lacking the terminal hydrazide NH moiety showed modest Gram-negative activity at 64 μg mL-1. 4-t-Butyl 45 was Gram -positive and -negative active at of 16 - 64 μg mL-1. Typically additional aromatic moiety modification was poorly tolerated, except with concomitant introduction of an imine C-alkyl moiety. The activity of these analogues against MRSA and VRE ranged from 8 μg mL-1 with 64 and 68, to inactive (MIC > 128 μg mL-1) with the naphthyl 69 and 70 and the indole 73. Gram-negative activity was most promising with 62 and 68 at 16 μg mL-1 against E. coli. Against Ps. aeruginosa, the highest activity observed was with MIC values of 32 μg mL-1 with 62 and 64. Combined, these findings support the further development of the (E)-2-benzylidenehydrazine-1-carboximidamide scaffold as a promising Gram-positive and Gram-negative antibiotic development.
Keywords: Antibiotics; drug repurposing; MRSA; robenidine; VRE
Rights: © 2018 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
RMID: 0030100489
DOI: 10.1002/cmdc.201800463
Grant ID: http://purl.org/au-research/grants/arc/LP110200770
Appears in Collections:Animal and Veterinary Sciences publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.